Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal

Journal of Immunological Methods

Volumn 409, Issue , 2014, Pages 9-20

  Ducar, Constance ^a,b   Smith, Donna ^a,b   Pinzon, Cris ^a,b   Stirewalt, Michael ^a,b   Cooper, Cristine ^a   McElrath, M Juliana ^a,b,c   Hural, John ^a,b  

^a USA   (United States)

^b HIV Vaccine Trials Network   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Clinical trials; Cryopreservation; HIV; Immune monitoring; Peripheral blood mononuclear cells; Quality assurance

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CERTIFICATION; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CONTROLLED STUDY; CRYOPRESERVATION; DATA BASE; DRUG DESIGN; EXTERNAL QUALITY CONTROL; FREEZE THAWING; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOLOGICAL MONITORING; INFORMATION PROCESSING; INTERNAL QUALITY CONTROL; LABORATORY TEST; MULTICENTER STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY CONTROL PROCEDURES; TOTAL QUALITY MANAGEMENT; WEB BROWSER;

CLINICAL TRIALS; CRYOPRESERVATION; HIV; IMMUNE MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELLS; QUALITY ASSURANCE;

AIDS VACCINES; CELL SURVIVAL; CERTIFICATION; CLINICAL TRIALS AS TOPIC; CONSENSUS; COOPERATIVE BEHAVIOR; CRYOPRESERVATION; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; IMMUNOLOGIC TESTS; INSERVICE TRAINING; INTERNATIONAL COOPERATION; INTERNET; LABORATORIES; LABORATORY PERSONNEL; LABORATORY PROFICIENCY TESTING; LEUKOCYTES, MONONUCLEAR; MONITORING, IMMUNOLOGIC; OBSERVER VARIATION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; SYSTEMS INTEGRATION; TIME FACTORS; TREATMENT OUTCOME; WORKFLOW;

EID: 84906094741     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.03.024     Document Type: Article

References (12)

1. Aziz N., Margolick J.B., Detels R., Rinaldo C.R., Phair J., Jamieson B.D., Butch A.W. Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study. Clin. Vaccine Immunol. 2013, 20:590.
2. Bull M., Lee D., Stucky J., Chiu Y.L., Rubin A., Horton H., McElrath M.J. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 2007, 322:57.
3. Dyer W.B., Pett S.L., Sullivan J.S., Emery S., Cooper D.A., Kelleher A.D., Lloyd A., Lewin S.R. Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples. Clin. Vaccine Immunol. 2007, 14:52.
4. Horton H., Thomas E.P., Stucky J.A., Frank I., Moodie Z., Huang Y., Chiu Y.L., McElrath M.J., De Rosa S.C. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J. Immunol. Methods 2007, 323:39.
5. Kierstead L.S., Dubey S., Meyer B., Tobery T.W., Mogg R., Fernandez V.R., Long R., Guan L., Gaunt C., Collins K., Sykes K.J., Mehrotra D.V., Chirmule N., Shiver J.W., Casimiro D.R. Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC. AIDS Res. Hum. Retroviruses 2007, 23:86.
6. Mallone R., Mannering S.I., Brooks-Worrell B.M., Durinovic-Bello I., Cilio C.M., Wong F.S., Schloot N.C., T-Cell Workshop Committee I.o.D.S. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin. Exp. Immunol. 2011, 163:33.
7. Peiperl L., Morgan C., Moodie Z., Li H., Russell N., Graham B.S., Tomaras G.D., De Rosa S.C., McElrath M.J., Network N.H.V.T. Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054). PLoS One 2010, 5:e13579.
8. Riccio E.K., Neves I., Banic D.M., Corte-Real S., Alecrim M., Morgado M., Daniel-Ribeiro C.T., Ferreira-da-Cruz Mde F. Cryopreservation of peripheral blood mononuclear cells does not significantly affect the levels of spontaneous apoptosis after 24-h culture. Cryobiology 2002, 45:127.
9. Sigma-Aldrich Histopaque-1077 Product Information 2011, vol. 2013.
10. Smith J.G., Joseph H.R., Green T., Field J.A., Wooters M., Kaufhold R.M., Antonello J., Caulfield M.J. Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clin. Vaccine Immunol. 2007, 14:527.
11. Weinberg A., Zhang L., Brown D., Erice A., Polsky B., Hirsch M.S., Owens S., Lamb K. Viability and functional activity of cryopreserved mononuclear cells. Clin. Diagn. Lab. Immunol. 2000, 7:714.
12. Weinberg A., Louzao R., Mussi-Pinhata M.M., Cruz M.L., Pinto J.A., Huff M.F., de Castro A.C., Sucupira M.C., Denny T.N. Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clin. Vaccine Immunol. 2007, 14:1242.